Embla Medical hf. (LON:0FIW)

Market Cap	1.51B
Revenue (ttm)	663.95M
Net Income (ttm)	55.86M
Shares Out	n/a
EPS (ttm)	0.13
PE Ratio	26.98
Forward PE	24.08
Dividend	n/a
Ex-Dividend Date	n/a

Volume	74
Average Volume	11,988
Open	29.50
Previous Close	n/a
Day's Range	29.50 - 29.50
52-Week Range	3.12 - 4.13
Beta	0.58
RSI	42.87
Earnings Date	Jul 22, 2025

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1971
• Employees: 4,061
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0FIW

Financial Performance

In 2024, Embla Medical's revenue was $854.89 million, an increase of 8.81% compared to the previous year's $785.68 million. Earnings were $68.28 million, an increase of 16.94%.

Financial numbers in USD